Skip to main content
. 2017 Feb;8(1):89–95. doi: 10.21037/jgo.2016.12.03

Table 2. Variables associated with overall survival in univariate and multivariate analysis for all patients.

Variable Reference level HR (95% CI)
Univariate analysis Multivariate analysis
Age 1.01 (1.00–1.01) 1.01 (1.01–1.01)
Grade
   III/IV I/II 1.32 (1.29–1.36) 1.22 (1.19–1.26)
   Unknown I/II 1.08 (1.04–1.13) 0.93 (0.90–0.97)
Stage
   Distant Localized 2.90 (2.80–3.00) 2.44 (2.35–2.52)
   Regional Localized 1.36 (1.31–1.41) 1.63 (1.57–1.69)
Nodes examined
   Unknown No 1.07 (0.95–1.21) 0.96 (0.85–1.09)
   Yes No 0.41 (0.40–0.43) 0.78 (0.74–0.82)
Race
   Black White 1.31 (1.26–1.36) 1.15 (1.10–1.20)
   Other White 1.08 (1.02–1.15) 0.95 (0.90–1.01)
Radiation
   Yes No 0.76 (0.74–0.78) 0.62 (0.60–0.63)
Gender
   Female Male 1.02 (0.99–1.05) 0.95 (0.92–0.98)
Histology
   ACA ASC 0.76 (0.67–0.87) 0.86 (0.76–0.98)
   SqCC ASC 0.93 (0.81–1.06) 0.96 (0.84–1.09)
Site
   Lower/abdominal Upper/cervical 0.91 (0.86–0.95) 1.06 (1.01–1.12)
   NOS Upper/cervical 1.24 (1.17–1.32) 1.20 (1.13–1.27)
   Mid/thoracic Upper/cervical 1.07 (1.01–1.13) 1.10 (1.04–1.16)
Surgery
   No resection Resection 2.84 (2.74–2.93) 2.06 (1.94–2.18)

ACA, adenocarcinoma; ASC, adenosquamous carcinoma; SqCC, squamous cell carcinoma; HR, hazard ratio; CI, confidence interval; NOS, not otherwise specified.